physical and learning disabilities ABOUT ANGELMAN SYNDROME Angelman syndrome is rare and affects roughly 1 in 15000 people ABOUT ANGELMAN SYNDROME There are approximately 500000 individuals globally living with Angelman syndrome ID: 1006517
Download Presentation The PPT/PDF document "Angelman syndrome is a genetic condition..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. Angelman syndrome is a genetic condition that can cause physical and learning disabilities.ABOUT ANGELMAN SYNDROME
2. Angelman syndrome is rare and affects roughly 1 in 15,000 people.ABOUT ANGELMAN SYNDROME
3. There are approximately 500,000 individuals globally living with Angelman syndrome.ABOUT ANGELMAN SYNDROME
4. Symptoms of Angelman syndrome include learning and speech difficulties, problems with balance and movement, disrupted sleep and seizures.ABOUT ANGELMAN SYNDROME
5. Other characteristics associated with Angelman syndrome include frequent laughing and smiling, being easily over-excited, and a fascination with water.ABOUT ANGELMAN SYNDROME
6. The life expectancy of people with Angelman syndrome is normal.ABOUT ANGELMAN SYNDROME
7. Individuals living with Angelman syndrome are universally unable to speak vocally…but they have a LOT to say!ABOUT ANGELMAN SYNDROME
8. Most of those with Angelman syndrome will require significant lifelong support.ABOUT ANGELMAN SYNDROME
9. Angelman syndrome is caused by problems with a gene located on chromosome 15, called the UBE3A gene.ABOUT ANGELMAN SYNDROME
10. Currently, there is no cure for Angelman syndrome.ABOUT ANGELMAN SYNDROME
11. With increased awareness and research, there is hope for treatments to enhance the lives of individuals with Angelman syndrome.ABOUT ANGELMAN SYNDROME
12. The Foundation for Angelman Syndrome Therapeutics (FAST) is dedicated to finding a cure for Angelman syndrome for all individuals, regardless of age or genotype, by identifying and funding translational research leading to transformative therapeutics enabling all individuals to realize their full potential and quality of life.ABOUT FAST
13. FAST has affiliates in Latin America, Australia, Canada, Colombia, France, Italy, Spain, and the UK.ABOUT FAST
14. Over 90% of every dollar donated to FAST supports critical research.ABOUT FAST
15. FAST launched in 2008. Since then, FAST has invested over $25 million to help bring transformative therapeutics to humans living with AS.ABOUT FAST
16. FAST has funded 10 gene therapy/disease modification-based programs to support drug development for Angelman syndrome.ABOUT FAST
17. 15 of the 33 potential Angelman syndrome therapeutics in the pipeline Are robustly funded by FAST.ABOUT FAST
18. FAST funds over 20 academic research laboratories to understand the etiology and identify treatment options for Angelman syndrome.ABOUT FAST
19. FAST has directed over $3 million to create novel animal models of Angelman syndrome.ABOUT FAST
20. FAST is a leading innovator in rare disease research and launched a biotech company to advance the first disease modifying therapy into a human clinical trial.ABOUT FAST